You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Resection

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumor Trial in Shenzhen (DC-CTL)

Recruiting
  • Malignant Tumor
  • DC-CTL
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
Dec 16, 2020

Solid Tumor, Adult Trial in Seoul (TAS-117)

Completed
  • Solid Tumor, Adult
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 21, 2021

Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Portland (Ibrutinib, Paclitaxel, Gemcitabine)

Completed
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • San Francisco, California
  • +1 more
Apr 13, 2021

Brain Tumor, Metastatic Brain Tumor Trial in New York (Resting-state functional connectivity MRI, Neurocognitive battery with

Recruiting
  • Brain Tumor
  • Metastatic Brain Tumor
  • Resting-state functional connectivity MRI
  • Neurocognitive battery with quality-of-life assessment
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 21, 2022

NSCLC, Malignant Solid Tumor Trial in United States (enzastaurin, erlotinib)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Malignant Solid Tumor
  • Los Angeles, California
  • +9 more
Apr 20, 2021

Glioblastoma Trial in New York (Ketogenic Diet, Metformin)

Recruiting
  • Glioblastoma
  • New York, New York
  • +1 more
Dec 21, 2021

Opioid Free Anesthesia Trial in Beijing (Paravertebral block+Anterior serratus plane block, opioid free anesthesia, opioid based

Unknown status
  • Opioid Free Anesthesia
  • Paravertebral block+Anterior serratus plane block
  • +2 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 6, 2020

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug, procedure, device)

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

ctDNA Methylation for Detecting Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +8 more
  • Methylation assay
  • Beijing, Beijing, China
    Lei Li
Mar 24, 2023

Pancreatic Cancer Trial in France (cisplatin, docetaxel, fluorouracil)

Completed
  • Pancreatic Cancer
  • Angers, France
  • +9 more
Feb 15, 2021

Childhood Atypical Teratoid/Rhabdoid Tumor Trial in Australia, Canada, United States (radiation, procedure, drug, biological,

Active, not recruiting
Has Results
  • Childhood Atypical Teratoid/Rhabdoid Tumor
  • 3-Dimensional Conformal Radiation Therapy
  • +11 more
  • Birmingham, Alabama
  • +93 more
Feb 25, 2022

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,

Active, not recruiting
Has Results
  • Colon Adenocarcinoma
  • +8 more
  • Clobetasol Propionate
  • +3 more
  • Phoenix, Arizona
  • +21 more
Jan 5, 2022

Newly Diagnosed Glioblastoma in Patients =70 Years Trial in Heidelberg (TTFields)

Suspended
  • Newly Diagnosed Glioblastoma in Patients ≥70 Years
  • TTFields
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Sep 28, 2021

Local Recurrence of Malignant Tumor of Prostate Trial in France (Stereotactic Body Radiotherapy)

Recruiting
  • Local Recurrence of Malignant Tumor of Prostate
  • Stereotactic Body Radiotherapy
  • Caen, France
  • +12 more
Sep 28, 2021

Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft

Completed
  • Bone Neoplasm
  • Bioactive glass
  • +3 more
  • Helsinki, Finland
  • +4 more
Mar 12, 2021

Metastatic Hepatocellular Carcinoma, HCC, Combinations of Drugs; Dependence Trial in Tainan, Taipei (GT90001 and Nivolumab)

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +2 more
  • GT90001 and Nivolumab
  • Tainan, Taiwan
  • +2 more
Jul 8, 2021

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 10, 2022

Hepatocellular Carcinoma Trial in Beijing (Apatinib Mesylate +SHR-1210, Hepatic Arterial Infusion(HAI))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Apatinib Mesylate +SHR-1210
  • Hepatic Arterial Infusion(HAI)
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Feb 11, 2019

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in

Completed
  • Adult Primary Hepatocellular Carcinoma
  • +4 more
  • Chinese herbal formulation PHY906
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 26, 2021

Breastcancer Trial in Ghent (WBI 5 fractions, WBI 15 fractions, LNI 5 fractions)

Recruiting
  • Breastcancer
  • WBI 5 fractions
  • +7 more
  • Ghent, Belgium
    Ghent University Hospital, Dept. Radiotherapy-Oncology
Oct 24, 2019

Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Cancer Of Prostate
  • M9241
  • Stereotactic Body Radiation Therapy (SBRT)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023

Malignant Melanoma, Lung Cancer, or Colorectal Cancer Trial in Suzhou (TAA06 injection)

Recruiting
  • Malignant Melanoma, Lung Cancer, or Colorectal Cancer
  • TAA06 injection
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics(Suzhou) Co., Ltd.
Dec 29, 2021

Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion

Recruiting
  • Advanced Malignant Solid Tumors
  • HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion stage with recommended dose of therapeutic cycle of 28 days .
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 30, 2021